(Q84156772)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

The comparative immunogenicity of human and porcine factor VIII in haemophilia A mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

John F Healey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ernest T Parker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Rachel T Barrow

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Travis J Langley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

William R Church

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Pete Lollar

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 July 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

Thrombosis and Haemostasis

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

35-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

The humoral response to human factor VIII in hemophilia A mice

1 February 2020

cites work

1 reference

12 December 2020

Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII

1 reference

12 December 2020

Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A.

1 reference

12 December 2020

A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor

1 reference

12 December 2020

Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance

1 reference

12 December 2020

Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII.

1 reference

12 December 2020

Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII

1 reference

12 December 2020

Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor

1 reference

12 December 2020

Investigation of porcine parvovirus among persons with hemophilia receiving Hyate:C porcine factor VIII concentrate

1 reference

12 December 2020

Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.

1 reference

12 December 2020

Mechanism of the immune response to human factor VIII in murine hemophilia A

1 reference

12 December 2020

Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid

1 reference

12 December 2020

Identification of a F.VIII epitope recognized by a human hemophilic inhibitor

1 reference

12 December 2020

Comparative immunogenicity of recombinant B domain-deleted porcine factor VIII and Hyate:C in hemophilia A mice presensitized to human factor VIII.

1 reference

12 December 2020

High level expression of recombinant porcine coagulation factor VIII.

1 reference

12 December 2020

Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C-mediated proteolysis

1 reference

12 December 2020

Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.

1 reference

12 December 2020

The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.

1 reference

12 December 2020

Structure of human factor VIII

1 reference

12 December 2020

Inhibitor development in previously untreated patients with hemophilia A: a prospective long-term follow-up comparing plasma-derived and recombinant products

1 reference

12 December 2020

Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.

1 reference

12 December 2020

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

1 reference

12 December 2020

Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation

1 reference

12 December 2020

Nonclassical anti-C2 domain antibodies are present in patients with factor VIII inhibitors

1 reference

12 December 2020

Some human inhibitor antibodies interfere with factor VIII binding to factor IX.

1 reference

12 December 2020

Proceedings: A more uniform measurement of factor VIII inhibitors

1 reference

12 December 2020

Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion.

1 reference

12 December 2020

Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope

1 reference

12 December 2020

The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A.

1 reference

12 December 2020

Expression and characterization of recombinant murine factor VIII

1 reference

12 December 2020

Residues 484-508 contain a major determinant of the inhibitory epitope in the A2 domain of human factor VIII

1 reference

12 December 2020

Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A

1 reference

12 December 2020

Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX.

1 reference

12 December 2020

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group

1 reference

12 December 2020

Porcine factor VIII: past, present and future.

1 reference

12 December 2020

Identifiers

DOI

10.1160/TH08-12-0818

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19572065%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

19572065

1 reference